EC Number |
Inhibitors |
Structure |
---|
1.10.3.11 | 2,6-dihydroxy-4-[[(2E,6E,10E)-12-hydroxy-2,6,10-trimethyldodeca-2,6,10-trien-1-yl]oxy]benzoic acid |
- |
|
1.10.3.11 | 2-fluoro-4-[[(2E,6E)-8-hydroxy-2,6-dimethylocta-2,6-dien-1-yl]oxy]benzoic acid |
- |
|
1.10.3.11 | 2-heptyl-4-hydroxyquinoline N-oxide |
i.e. HQNO, binds stoichiometrically to the enzyme and prevents formation of the ubisemiquinone at the QH-site, but does not displace the ubiquinone-8 bound at the QH-site, enzyme binding kineticss, overview |
|
1.10.3.11 | 2-Heptyl-4-hydroxyquinoline-N-oxide |
- |
|
1.10.3.11 | 2-hydroxy-4-[[(2E,6E)-8-hydroxy-2,6-dimethylocta-2,6-dien-1-yl]oxy]-6-methylbenzoic acid |
- |
|
1.10.3.11 | 2-hydroxy-4-[[(2E,6E)-8-hydroxy-2,6-dimethylocta-2,6-dien-1-yl]oxy]benzoic acid |
- |
|
1.10.3.11 | 2-hydroxybenzhydroxamic acid |
competitive inhibitor towards ubiquinol |
|
1.10.3.11 | 4-[(14-bromotetradecyl)oxy]-2-hydroxybenzaldehyde |
- |
|
1.10.3.11 | 4-[[(2E,6E)-8-hydroxy-2,6-dimethylocta-2,6-dien-1-yl]oxy]-2-methylbenzoic acid |
- |
|
1.10.3.11 | 5-chloro-3-[(2E)-3,7-dimethylocta-2,6-dienyl]-2,4-dihydroxy-6-methylbenzaldehyde |
an ascofuranone derivative |
|